Literature DB >> 25868619

Angiotensin-converting enzyme (ACE) inhibitory potential of standardized Mucuna pruriens seed extract.

Sushil Kumar Chaudhary1, Apurba De, Santanu Bhadra, Pulok K Mukherjee.   

Abstract

CONTEXT: Mucuna pruriens Linn. (Fabaceae) is a tropical legume, traditionally used for controlling blood pressure. Inhibition of angiotensin-converting enzyme (ACE) is one of the successful strategies for controlling hypertension.
OBJECTIVE: The present study evaluated the ACE inhibition potential of the standardized extract of M. pruriens seeds.
MATERIALS AND METHODS: Standardization of the extract and its fractions were carried out by RP-HPLC method [methanol and 1% v/v acetic acid in water (5:95 v/v)] using levodopa as a marker. The ACE inhibition activity of the extract and fractions was evaluated at different concentrations (20, 40, 60, 80, and 100 µg/mL) using the HPLC-DAD and the UV spectrophotometric method. The liberation of hippuric acid (HA) from hippuryl-L-histidyl-L-leucine (HHL) was estimated in the spectrophotometric method and RP-HPLC assay at 228 nm.
RESULTS: Methanol extract and aqueous fraction showed a maximum activity with IC50 values of 38.44 ± 0.90 and 57.07 ± 2.90 µg/mL (RP-HPLC), and 52.68 ± 2.02 and 67.65 ± 2.40 µg/mL (spectrophotometry), respectively. DISCUSSION: The study revealed that the aqueous extract contains the highest amount of levodopa. Eventually the methanol extract showed highest ACE inhibition activity except levodopa alone. It was further observed that the inhibition was altered with respect to the change in the content of levodopa in the extract. Thus, it can be assumed that levodopa may be responsible for the ACE inhibition activity of M. pruriens seeds.
CONCLUSION: It can be concluded that M. pruriens seed is a potential ACE inhibitor can be explored further as an effective antihypertensive agent.

Entities:  

Keywords:  Captopril; HPLC; hippuryl-l-histidyl-l-leucine; hypertension; levodopa; standardization

Mesh:

Substances:

Year:  2015        PMID: 25868619     DOI: 10.3109/13880209.2014.996820

Source DB:  PubMed          Journal:  Pharm Biol        ISSN: 1388-0209            Impact factor:   3.503


  3 in total

1.  Biologically Synthesized Peptides Show Remarkable Inhibition Activity against Angiotensin-Converting Enzyme: A Promising Approach for Peptide Development against Autoimmune Diseases.

Authors:  Nosheen Mujtaba; Nazish Jahan; Adil Jamal; Shazia Abrar; Shumaila Kiran; Atizaz Rasool; Md Belal Hossain; Fayez Saeed Bahwerth; Ibtesam Nomani; Khalid Javed Iqbal
Journal:  Biomed Res Int       Date:  2022-06-20       Impact factor: 3.246

Review 2.  Review of Angiotensin-converting Enzyme Inhibitory Assay: Rapid Method in Drug Discovery of Herbal Plants.

Authors:  Islamudin Ahmad; Arry Yanuar; Kamarza Mulia; Abdul Mun'im
Journal:  Pharmacogn Rev       Date:  2017 Jan-Jun

Review 3.  An Insight into GPCR and G-Proteins as Cancer Drivers.

Authors:  Preeti Kumari Chaudhary; Soochong Kim
Journal:  Cells       Date:  2021-11-24       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.